23andme Holding Co (ME) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
23andme Holding Co  (ME)


23andme Holding Co's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is 23andme Holding Co's ROI in the first quarter of 2026?
23andme Holding Co recorded a cumulative net loss of $-235 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -229.39%.

Within the Healthcare sector 827 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 3676 to 4400.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2025)
I. Quarter		 (Mar 31 2025)
IV. Quarter		 (Dec 31 2024)
III. Quarter		 (Sep 30 2024)
II. Quarter		 (Jun 30 2024)
I. Quarter
Y / Y Investment Change TTM -75.08 % -72.87 % -71.46 % -63.74 % -49.58 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 33 87 124 166 215
Return On Investment (TTM) -229.39 % -189.61 % -201.95 % -221.1 % -153.39 %
ME's Overall Ranking # 4400 # 3676 # 3121 # 3520 # 2139
Seq. Investment Change TTM -30.75 % -23.36 % -30.54 % -32.4 % -24.59 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -235 -281 -390 -615 -631

ME Company Profile >> Back to ME Roi Comparisons >> See Annual ME Return On Investment



Return On Investment ME's Ranking
Within: No.
Industry # 391
Sector # 828
Overall # 4400

Return On Investment Statistics
High Average Low
20.92 %
-89.3 %
-229.39 %
(Mar 31 2021)   (Jun 30 2025)







Financial Statements
23andme Holding Co's I. Quarter Investments $ 33 Millions ME's Balance sheet
23andme Holding Co's I. Quarter Income $ -24 Millions Quarterly ME's Income Statement
ME's Income by Division See ME's Income by Division


ME Annual Return On Investment (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2022)
2022
Total Investments in Millions 87 268 793 999 0
Y / Y Investment Growth -67.45 % -66.23 % -20.59 % - -
Net Income in Millions -281 -667 -312 -217 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -322.15 % -248.92 % -39.29 % -21.77 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ME's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ME's Competitors
Subscribers only: Roi for 23andme Holding Co's Suppliers
Subscribers only: Return On Investment for ME's Customers

Other Ratios
ME's Roa ME's Inventory Turnover Ratio ME's Growth Rates ME's Dividend Statistics
ME's Profitability Ratios ME's Asset Turnover Ratio ME's Dividend Growth
ME's Roe ME's Valuation Ratios ME's Financial Strength Ratios ME's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI

Date modified: 2026-09-26T07:39:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.